Idexx Laboratories is a global leader in veterinary diagnostics, providing a wide range of innovative products and services that enhance animal health and well-being
The company develops and manufactures diagnostic tests and equipment for companion animals, livestock, and poultry, helping veterinarians and livestock producers make informed health decisions. Additionally, Idexx offers various software solutions for practice management and laboratory information, along with water testing services to ensure public safety and environmental protection. With a commitment to advancing veterinary medicine and improving animal care, Idexx plays a crucial role in the healthcare ecosystem for animals and the people who care for them.
Let's have a look at what is happening on the US markets in the middle of the day on Monday. Below you can find the top S&P500 gainers and losers in today's session.
Wall Street bounced back after President Donald Trump and Mexican President Claudia Sheinbaum agreed to a one-month suspension of tariffs following Mexico's pledge to bolster its military presence at the northern borde
Idexx Laboratories posted strong Q4 earnings, beating estimates with 10% EPS growth. 2025 guidance reflects up to 7% revenue growth and $1.5 billion in buybacks.
Katy Huberty, the Global Head of Research at Morgan Stanley, has spotlighted 20 stocks from companies that are likely to see significant benefits from the adoption of Artificial Intelligence (AI).
JP Morgan highlights 2025 growth prospects for biopharma, animal health, and specialty pharma stocks. Key picks include Eli Lilly, Zoetis, and Bristol-Myers Squibb.
Is it a good time to scoop up last month's biggest losers? Check out October's largest price drops on the Nasdaq, and see whether any of them look like good buys today.
Idexx Laboratories posted a Q3 EPS of $2.79, beating estimates, though revenue of $975.54 million fell short. Veterinary trends and guidance update key 2024 outlook.
